Xiaolin Wang's most recent trade in Revolution Medicines Inc was a trade of 2,718 Common Stock done . Disclosure was reported to the exchange on March 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Mar 2025 | 2,718 | 102,321 (0%) | 0% | 0 | Common Stock | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 66,500 | 66,500 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 19,000 | 105,039 (0%) | 0% | 0 | Common Stock | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 84,700 | 84,700 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 24,200 | 84,526 (0%) | 0% | 0 | Common Stock | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Sale of securities on an exchange or to another person at price $ 21.78 per share. | 17 Mar 2023 | 714 | 58,813 (0%) | 0% | 21.8 | 15,551 | Common Stock |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 101,500 | 101,500 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 29,000 | 59,527 (0%) | 0% | 0 | Common Stock | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Sale of securities on an exchange or to another person at price $ 22.94 per share. | 19 Dec 2022 | 708 | 30,527 (0%) | 0% | 22.9 | 16,241 | Common Stock |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Sale of securities on an exchange or to another person at price $ 19.04 per share. | 19 Sep 2022 | 735 | 31,235 (0%) | 0% | 19.0 | 13,996 | Common Stock |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 17 Jun 2022 | 665 | 31,970 (0%) | 0% | 17.7 | 11,803 | Common Stock |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 17 Mar 2022 | 240 | 31,698 (0%) | 0% | 18.6 | 4,467 | Common Stock |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 20,000 | 31,938 (0%) | 0% | 0 | Common Stock | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 17 Sep 2021 | 250 | 12,195 (0%) | 0% | 30.0 | 7,505 | Common Stock |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Sale of securities on an exchange or to another person at price $ 34.12 per share. | 17 Jun 2021 | 243 | 12,445 (0%) | 0% | 34.1 | 8,291 | Common Stock |
Greenland Technologies Hol... | Everett Xiaolin Wang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 2,500 | 2,500 (0%) | 0% | - | Ordinary Shares | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 39,200 | 39,200 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Xiaolin Wang | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 11,200 | 11,944 (0%) | 0% | 0 | Common Stock |